Community Engagement and Virtual Meetings

Virtual Community Meetings


About our application to extend the Development Agreement 

In 1992, the City of Berkeley and Miles Inc (now Bayer HealthCare LLC) entered into a 30-year Development Agreement (DA) that planned for long-term development and investment in one of the earliest biopharmaceutical manufacturing facilities. Through the years, the DA framework has provided consistent benefits to the community and to Bayer. In March 2020, Bayer applied to extend that agreement to set the stage for completing its master plan over the next 30 years.


Learn more about the planned changes at Bayer’s Berkeley campus here.


Click here to see all the documents associated with the city's review of Bayer's application.


For information on the economic impact of this development, please review the Bay Area Council Economic Institute's Economic Impact Analysis, available here.


View previous community meetings:


Check here for information about upcoming community meetings.

About our planned Cell Therapy Launch Facility

Bayer’s new production center will serve a growing need for specialized medicines. The facility represents a new generation of campus infrastructure which will enable agile and flexible manufacturing. The building is designed to allow for development and launch of a variety of treatments. Learn more (PDF).


View community meetings: